Landiolol Completed Phase 2 Trials for Coronary Artery Disease Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT00560209Study of ONO-1101 in Patients Scheduled for Coronary Angiography
NCT00311038Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT